On the recordFebruary 24, 2016
It is really troubling to me that they have not issued final guidance.
Source
congress.govEditor's note · Context
Ayotte expresses frustration over the FDA's delay in providing guidance for compassionate use.
Share & report
More from Kelly Ayotte
Apr 12, 2016
I have been one of the lead sponsors of the Improving Treatment for Pregnant and Postpartum Women Act of 2016.
May 25, 2016
I think it is really important for this Committee to understand whether any of the individuals that we know were involved in Paris--that have been identified in Brussels--were they on the 'terrorist watchlist?'
Sep 26, 2016
We want to be sure that consumers continue to have options for care in their communities that are cost-effective.
Other voices in this conversation
